查看購物車
  • English
封面
市場調查報告書
商品編碼
1914627

生物技術試劑盒市場 - 全球產業規模、佔有率、趨勢、機會及預測（按試劑盒類型、技術、檢測參數、微生物、應用、最終用戶、地區和競爭格局分類），2021-2031年

Biotechnology Kits Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Kit Type, By Technology, By Parameter Tested, By Microorganism, By Purpose, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 186 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球生物技術試劑盒市場預計將從2025年的5.7818億美元成長到2031年的10.4456億美元，複合年成長率（CAGR）為10.36%。這些試劑盒包含預先包裝的試劑、緩衝液和通訊協定，旨在簡化和標準化生物實驗，包括基因組分析、蛋白質純化和診斷檢測。推動該市場成長要素包括感染疾病和慢性病的日益增多（這些疾病需要高效的診斷流程）以及對藥物研發的持續投入。根據國際藥品製造商協會聯合會（IFPMA）統計，2023年該產業提交了12425項國際專利申請，這表明依賴這些標準化工具的廣泛研究活動的重要性。

市場概覽
預測期 2027-2031
市場規模：2025年 5.7818億美元
市場規模：2031年 1,044,560,000 美元
複合年成長率：2026-2031年 10.36%
成長最快的細分市場 淨化套裝
最大的市場 北美洲

儘管市場成長迅速，但由於嚴格的監管要求，仍面臨許多障礙。衛生監管機構對臨床級和診斷試劑盒的複雜核准程序，往往導致製造商承擔高昂的財務成本，並延遲產品上市。這些監管障礙會減緩新產品交付給終端用戶的速度，並阻礙成本敏感地區對專業試劑盒的採用。

市場促進因素

生命科學領域研發投入的不斷成長是全球生物技術試劑盒市場的主要驅動力。隨著製藥和生技公司加強探索新治療方法，大量資金正投入標準化實驗室工具的研發中，以確保實驗的可重複性和效率。這些資金的湧入推動了基因組學和蛋白​​質組學試劑盒的廣泛應用，而這些試劑盒對於臨床前試驗和早期藥物發現至關重要。例如，默克公司於2024年3月發布的《2023年度報告》顯示，其年度研發支出達305億美元，顯示維持創新需要巨額投資。這種研發強度也反映在監理核准的里程碑事件中。美國食品藥物管理局（FDA）於2024年1月發布的《2023年新藥核准報告》指出，共有55種新藥核准，顯示依賴這些關鍵試劑盒的研發活動十分活躍。

同時，感染疾病和慢性病的日益增多，迫切需要廣泛採用先進的診斷和監測解決方案。癌症和心血管疾病等疾病負擔的不斷加重，推動了對用於生物標記檢測、疾病分析和患者分層的生物技術試劑盒的需求。這些即用型試劑盒對於需要快速、準確檢測且無需複雜內部製備的臨床檢查室至關重要。為了強調這一緊迫性，世界衛生組織（世衛組織）於2024年2月發布新聞稿，指出全球癌症負擔日益加重，並估計2022年全球將新增2,000萬例癌症病例。這場日益嚴峻的健康危機迫使醫療服務提供者和研究人員採用高通量診斷工作流程，從而確保生物技術試劑盒在學術和臨床環境中持續且廣泛地應用。

市場挑戰

嚴格的監管合規和複雜的核准流程對全球生物技術試劑盒市場的成長構成了重大障礙。衛生監管機構對用於診斷或臨床的試劑盒實施嚴格的檢驗標準，要求提供大量文件並經歷漫長的審查週期。這些要求導致營運成本高昂，延長產品商業化週期，並迫使製造商將資源從創新轉移到合規管理。因此，這種環境減緩了新技術的引入，增加了現有產品線維護的難度，並直接降低了先進研究工具到達最終用戶的速度。

這種監管壓力導致企業採取策略性撤出和改變打入市場策略，阻礙了整體市場擴張。當符合嚴格標準的成本超過潛在效益時，企業往往會延遲產品上市或完全停止某些產品的生產。根據歐洲醫療技術協會 (MedTech Europe) 2024 年的一份報告，日益增多的監管障礙導致選擇歐盟作為新產品上市優先區域的領先體外診斷試劑製造商數量下降了 40%。這些趨勢限制了關鍵地區專業試劑盒的供應，最終限制了全球產業的收入潛力和發展速度。

市場趨勢

人工智慧 (AI) 和機器學習 (ML) 的融合正透過改進實驗設計和數據解讀，從根本上改變全球生物技術試劑盒市場。隨著基因測序和蛋白質組學分析試劑盒產生日益複雜的資料集，研究人員正利用人工智慧驅動的演算法來識別模式並更準確地檢驗生物標記。這推動了從提供簡單試劑到提供完整分析解決方案的轉變。這種數位化轉型正迅速成為實驗室的標配，迫使製造商確保其產品與先進的運算工具相容。根據皮斯托亞聯盟 (Pistoia Alliance) 2025 年 9 月發布的「未來實驗室」調查，77% 的生命科學實驗室計劃在未來兩年內使用人工智慧技術，這凸顯了對支援高級數據分析的工作流程解決方案的巨大需求。

同時，市場正發生顯著轉變，轉向液態生物檢體和非侵入性診斷解決方案，推動了循環腫瘤DNA (ctDNA) 和遊離DNA (cfDNA) 提取專用試劑盒的研發。由於臨床上需要頻繁監測患者，同時避免傳統組織切片檢查帶來的風險，這一趨勢導致對能夠檢測血液樣本中低濃度生物標記的高靈敏度試劑的需求激增。這些微創檢測方法的快速普及也反映在商業性績效上。 Guardant Health於2025年10月發布的「2025會計年度第三季收益」新聞稿顯示，其臨床腫瘤檢測量年增40%，反映出腫瘤診療流程中對血液診斷工具的依賴性日益增強。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球生物技術試劑盒市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依試劑盒類型（純化試劑盒、擴增試劑盒、檢測試劑盒、分離試劑盒等）
    • 透過技術（LAMP技術、PCR、細胞培養、定序、層析法、電泳等）
    • 依檢測參數（DNA、RNA、酵素、蛋白質等）
    • 微生物（細菌、真菌、病毒等）
    • 依應用領域（現場應用與實驗室應用）
    • 按最終用戶（醫療保健、食品和農業、工業流程、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章 北美生物技術試劑盒市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲生物技術試劑盒市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區生物技術試劑盒市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲生物技術試劑盒市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲生物技術試劑盒市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球生物技術試劑盒市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Thermo Fisher Scientific, Inc.
  • QIAGEN NV
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Merck KGaA
  • Promega Corporation
  • Takara Bio, Inc
  • New England Biolabs UK Limited

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 12900

The Global Biotechnology Kits Market is projected to expand from USD 578.18 Million in 2025 to USD 1044.56 Million by 2031, registering a CAGR of 10.36%. These kits comprise pre-packaged sets of reagents, buffers, and protocols intended to streamline and standardize biological experiments, including genomic analysis, protein purification, and diagnostic assays. The market is chiefly driven by the rising burden of infectious and chronic diseases, which demands efficient diagnostic workflows, alongside continuous investment in pharmaceutical research and development. According to the International Federation of Pharmaceutical Manufacturers and Associations, the industry filed 12,425 international patent applications in 2023, highlighting the extensive investigative activity that depends on these standardized tools.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 578.18 Million
Market Size 2031USD 1044.56 Million
CAGR 2026-203110.36%
Fastest Growing SegmentPurification Kits
Largest MarketNorth America

Despite this growth, the market faces significant obstacles due to strict regulatory compliance. The intricate approval procedures mandated by health authorities for clinical-grade and diagnostic kits often result in high financial costs and delayed market entry for manufacturers. These regulatory barriers slow the delivery of new products to end-users and can hinder the adoption of specialized kits in cost-sensitive regions.

Market Driver

Rising investments in life sciences research and development act as a primary catalyst for the Global Biotechnology Kits Market. As pharmaceutical and biotechnology companies ramp up efforts to discover new therapies, significant capital is directed toward standardized experimental tools that guarantee reproducibility and efficiency. This influx of funding supports the widespread use of genomic and proteomic kits essential for preclinical trials and early-stage drug discovery. For instance, Merck & Co.'s 'Annual Report 2023', released in March 2024, reported research and development expenses of $30.5 billion for the year, demonstrating the massive financial commitment needed to sustain innovation. This research intensity is reflected in regulatory milestones; the U.S. Food and Drug Administration's 'New Drug Therapy Approvals 2023' report from January 2024 noted the approval of 55 novel drugs, indicating high investigative activity reliant on these essential kits.

Concurrently, the increasing prevalence of infectious and chronic diseases necessitates the broad deployment of advanced diagnostic and monitoring solutions. The growing burden of conditions like cancer and cardiovascular disorders drives the demand for biotechnology kits used in biomarker detection, disease profiling, and patient stratification. These ready-to-use reagent sets are vital for clinical laboratories needing rapid, accurate assays without the complexity of in-house formulation. Underscoring this urgency, the World Health Organization's February 2024 press release on the growing global cancer burden estimated 20 million new cancer cases worldwide in 2022. This deepening health crisis compels healthcare providers and researchers to adopt high-throughput diagnostic workflows, ensuring the continuous and expanding use of biotechnology kits in both academic and clinical settings.

Market Challenge

Strict regulatory compliance and complex approval processes present a major barrier to the growth of the Global Biotechnology Kits Market. Health authorities enforce rigorous validation standards for kits intended for diagnostic or clinical use, requiring extensive documentation and lengthy review periods. These requirements create high operational costs and extend the timeline for product commercialization, forcing manufacturers to divert resources from innovation to compliance management. Consequently, this environment delays the introduction of new technologies and complicates the maintenance of existing product lines, directly reducing the speed at which advanced research tools reach end-users.

This regulatory pressure leads to strategic withdrawals and alters market entry tactics, impeding overall expansion. When the cost of meeting stringent standards outweighs potential returns, companies often delay launches or discontinue specific products entirely. According to MedTech Europe in 2024, the selection of the European Union as a priority region for new product launches by large in vitro diagnostic manufacturers declined by 40 percent due to these elevated regulatory hurdles. Such trends restrict the availability of specialized kits in major regions, ultimately limiting the revenue potential and developmental pace of the global industry.

Market Trends

The integration of artificial intelligence (AI) and machine learning (ML) is fundamentally transforming the Global Biotechnology Kits Market by improving experimental design and data interpretation. As genomic sequencing and proteomic analysis kits generate increasingly complex datasets, researchers are utilizing AI-driven algorithms to identify patterns and validate biomarkers with greater precision, moving beyond simple reagent provision to complete analytical solutions. This digital shift is rapidly becoming a standard expectation in laboratories, compelling manufacturers to ensure their products are compatible with sophisticated computational tools. According to the Pistoia Alliance's 'Lab of the Future Survey' from September 2025, 77 percent of life sciences laboratories plan to use artificial intelligence technologies within the next two years, highlighting the critical demand for workflow solutions that support advanced data analytics.

Simultaneously, there is a decisive market shift toward liquid biopsy and non-invasive diagnostic solutions, driving the development of specialized kits for circulating tumor DNA (ctDNA) and cell-free DNA (cfDNA) extraction. This trend is fueled by the clinical need for frequent patient monitoring without the risks associated with traditional tissue biopsies, creating a surge in demand for high-sensitivity reagents capable of detecting low-abundance biomarkers in blood samples. The rapid adoption of these less invasive testing modalities is evident in commercial performance; Guardant Health's 'Third Quarter 2025 Financial Results' press release from October 2025 reported a 40 percent year-over-year increase in clinical oncology test volume, reflecting the accelerating reliance on blood-based diagnostic tools in oncology workflows.

Key Market Players

  • Thermo Fisher Scientific, Inc.
  • QIAGEN N.V.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Merck KGaA
  • Promega Corporation
  • Takara Bio, Inc
  • New England Biolabs UK Limited

Report Scope

In this report, the Global Biotechnology Kits Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biotechnology Kits Market, By Kit Type

  • Purification Kits
  • Amplification Kits
  • Detection Kits
  • Isolation Kits
  • Others

Biotechnology Kits Market, By Technology

  • LAMP Technology
  • PCR
  • Cell Culture
  • Sequencing
  • Chromatography
  • Electrophoresis
  • Others

Biotechnology Kits Market, By Parameter Tested

  • DNA
  • RNA
  • Enzymes
  • Proteins
  • Others

Biotechnology Kits Market, By Microorganism

  • Bacteria
  • Fungi
  • Virus
  • Others

Biotechnology Kits Market, By Purpose

  • On-site v/s Laboratory

Biotechnology Kits Market, By End User

  • Healthcare
  • Food & Agriculture
  • Industrial Processing
  • Others

Biotechnology Kits Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biotechnology Kits Market.

Available Customizations:

Global Biotechnology Kits Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biotechnology Kits Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Kit Type (Purification Kits, Amplification Kits, Detection Kits, Isolation Kits, Others)
    • 5.2.2. By Technology (LAMP Technology, PCR, Cell Culture, Sequencing, Chromatography, Electrophoresis, Others)
    • 5.2.3. By Parameter Tested (DNA, RNA, Enzymes, Proteins, Others)
    • 5.2.4. By Microorganism (Bacteria, Fungi, Virus, Others)
    • 5.2.5. By Purpose (On-site v/s Laboratory)
    • 5.2.6. By End User (Healthcare, Food & Agriculture, Industrial Processing, Others)
    • 5.2.7. By Region
    • 5.2.8. By Company (2025)
  • 5.3. Market Map

6. North America Biotechnology Kits Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Kit Type
    • 6.2.2. By Technology
    • 6.2.3. By Parameter Tested
    • 6.2.4. By Microorganism
    • 6.2.5. By Purpose
    • 6.2.6. By End User
    • 6.2.7. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Biotechnology Kits Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Kit Type
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Parameter Tested
        • 6.3.1.2.4. By Microorganism
        • 6.3.1.2.5. By Purpose
        • 6.3.1.2.6. By End User
    • 6.3.2. Canada Biotechnology Kits Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Kit Type
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Parameter Tested
        • 6.3.2.2.4. By Microorganism
        • 6.3.2.2.5. By Purpose
        • 6.3.2.2.6. By End User
    • 6.3.3. Mexico Biotechnology Kits Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Kit Type
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Parameter Tested
        • 6.3.3.2.4. By Microorganism
        • 6.3.3.2.5. By Purpose
        • 6.3.3.2.6. By End User

7. Europe Biotechnology Kits Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Kit Type
    • 7.2.2. By Technology
    • 7.2.3. By Parameter Tested
    • 7.2.4. By Microorganism
    • 7.2.5. By Purpose
    • 7.2.6. By End User
    • 7.2.7. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Biotechnology Kits Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Kit Type
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Parameter Tested
        • 7.3.1.2.4. By Microorganism
        • 7.3.1.2.5. By Purpose
        • 7.3.1.2.6. By End User
    • 7.3.2. France Biotechnology Kits Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Kit Type
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Parameter Tested
        • 7.3.2.2.4. By Microorganism
        • 7.3.2.2.5. By Purpose
        • 7.3.2.2.6. By End User
    • 7.3.3. United Kingdom Biotechnology Kits Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Kit Type
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Parameter Tested
        • 7.3.3.2.4. By Microorganism
        • 7.3.3.2.5. By Purpose
        • 7.3.3.2.6. By End User
    • 7.3.4. Italy Biotechnology Kits Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Kit Type
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Parameter Tested
        • 7.3.4.2.4. By Microorganism
        • 7.3.4.2.5. By Purpose
        • 7.3.4.2.6. By End User
    • 7.3.5. Spain Biotechnology Kits Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Kit Type
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Parameter Tested
        • 7.3.5.2.4. By Microorganism
        • 7.3.5.2.5. By Purpose
        • 7.3.5.2.6. By End User

8. Asia Pacific Biotechnology Kits Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Kit Type
    • 8.2.2. By Technology
    • 8.2.3. By Parameter Tested
    • 8.2.4. By Microorganism
    • 8.2.5. By Purpose
    • 8.2.6. By End User
    • 8.2.7. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Biotechnology Kits Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Kit Type
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Parameter Tested
        • 8.3.1.2.4. By Microorganism
        • 8.3.1.2.5. By Purpose
        • 8.3.1.2.6. By End User
    • 8.3.2. India Biotechnology Kits Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Kit Type
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Parameter Tested
        • 8.3.2.2.4. By Microorganism
        • 8.3.2.2.5. By Purpose
        • 8.3.2.2.6. By End User
    • 8.3.3. Japan Biotechnology Kits Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Kit Type
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Parameter Tested
        • 8.3.3.2.4. By Microorganism
        • 8.3.3.2.5. By Purpose
        • 8.3.3.2.6. By End User
    • 8.3.4. South Korea Biotechnology Kits Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Kit Type
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Parameter Tested
        • 8.3.4.2.4. By Microorganism
        • 8.3.4.2.5. By Purpose
        • 8.3.4.2.6. By End User
    • 8.3.5. Australia Biotechnology Kits Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Kit Type
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Parameter Tested
        • 8.3.5.2.4. By Microorganism
        • 8.3.5.2.5. By Purpose
        • 8.3.5.2.6. By End User

9. Middle East & Africa Biotechnology Kits Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Kit Type
    • 9.2.2. By Technology
    • 9.2.3. By Parameter Tested
    • 9.2.4. By Microorganism
    • 9.2.5. By Purpose
    • 9.2.6. By End User
    • 9.2.7. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Biotechnology Kits Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Kit Type
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Parameter Tested
        • 9.3.1.2.4. By Microorganism
        • 9.3.1.2.5. By Purpose
        • 9.3.1.2.6. By End User
    • 9.3.2. UAE Biotechnology Kits Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Kit Type
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Parameter Tested
        • 9.3.2.2.4. By Microorganism
        • 9.3.2.2.5. By Purpose
        • 9.3.2.2.6. By End User
    • 9.3.3. South Africa Biotechnology Kits Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Kit Type
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Parameter Tested
        • 9.3.3.2.4. By Microorganism
        • 9.3.3.2.5. By Purpose
        • 9.3.3.2.6. By End User

10. South America Biotechnology Kits Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Kit Type
    • 10.2.2. By Technology
    • 10.2.3. By Parameter Tested
    • 10.2.4. By Microorganism
    • 10.2.5. By Purpose
    • 10.2.6. By End User
    • 10.2.7. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Biotechnology Kits Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Kit Type
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Parameter Tested
        • 10.3.1.2.4. By Microorganism
        • 10.3.1.2.5. By Purpose
        • 10.3.1.2.6. By End User
    • 10.3.2. Colombia Biotechnology Kits Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Kit Type
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Parameter Tested
        • 10.3.2.2.4. By Microorganism
        • 10.3.2.2.5. By Purpose
        • 10.3.2.2.6. By End User
    • 10.3.3. Argentina Biotechnology Kits Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Kit Type
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Parameter Tested
        • 10.3.3.2.4. By Microorganism
        • 10.3.3.2.5. By Purpose
        • 10.3.3.2.6. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Biotechnology Kits Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. QIAGEN N.V.
  • 15.3. Illumina, Inc.
  • 15.4. Agilent Technologies, Inc.
  • 15.5. Bio-Rad Laboratories, Inc.
  • 15.6. F. Hoffmann-La Roche AG
  • 15.7. Merck KGaA
  • 15.8. Promega Corporation
  • 15.9. Takara Bio, Inc
  • 15.10. New England Biolabs UK Limited

16. Strategic Recommendations

17. About Us & Disclaimer